Literature DB >> 25279409

Response to: assessing the harms of polypharmacy requires careful interpretation and consistent definitions.

Rupert A Payne, Gary A Abel, Anthony J Avery, Stewart W Mercer, Martin O Roland.   

Abstract

Mesh：

Year:  2014        PMID： 25279409      PMCID： PMC4243918          DOI： 10.1111/bcp.12358

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study.

Authors:  Alessandro Nobili; Giuseppe Licata; Francesco Salerno; Luca Pasina; Mauro Tettamanti; Carlotta Franchi; Luigi De Vittorio; Alessandra Marengoni; Salvatore Corrao; Alfonso Iorio; Maura Marcucci; Pier Mannuccio Mannucci
Journal:  Eur J Clin Pharmacol       Date:  2011-01-11       Impact factor: 2.953

2.  Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care.

Authors:  Rupert A Payne; Gary A Abel; Anthony J Avery; Stewart W Mercer; Martin O Roland
Journal:  Br J Clin Pharmacol       Date:  2014-06       Impact factor: 4.335

3.  Assessing the harms of polypharmacy requires careful interpretation and consistent definitions.

Authors:  Lisa Kouladjian; Sarah N Hilmer; Timothy F Chen; David G Le Couteur; Danijela Gnjidic
Journal:  Br J Clin Pharmacol       Date:  2014-09       Impact factor: 4.335

4.  Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes.

Authors:  Danijela Gnjidic; Sarah N Hilmer; Fiona M Blyth; Vasi Naganathan; Louise Waite; Markus J Seibel; Andrew J McLachlan; Robert G Cumming; David J Handelsman; David G Le Couteur
Journal:  J Clin Epidemiol       Date:  2012-06-27       Impact factor: 6.437

5.  Polypharmacy and excessive polypharmacy in octogenarians and older acutely hospitalized patients.

Authors:  Christoph Strehblow; Michael Smeikal; Peter Fasching
Journal:  Wien Klin Wochenschr       Date:  2014-01-21       Impact factor: 1.704

6.  High-risk prescribing and incidence of frailty among older community-dwelling men.

Authors:  D Gnjidic; S N Hilmer; F M Blyth; V Naganathan; R G Cumming; D J Handelsman; A J McLachlan; D R Abernethy; E Banks; D G Le Couteur
Journal:  Clin Pharmacol Ther       Date:  2012-02-01       Impact factor: 6.875
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.